| Previous Close | 127.38 |
| Open | 127.55 |
| Bid | 127.43 x 700 |
| Ask | 127.44 x 300 |
| Day's Range | 127.37 - 127.60 |
| 52 Week Range | 106.69 - 127.60 |
| Volume | 152,360 |
| Avg. Volume | 2,044,636 |
| Net Assets | 580.99B |
| NAV | 124.43 |
| PE Ratio (TTM) | N/A |
| Yield | 1.92% |
| YTD Return | 8.90% |
| Beta (3y) | 1.02 |
| Expense Ratio (net) | 0.04% |
| Inception Date | 2001-05-24 |
- Market Realist•21 hours ago
Abbott Laboratories’ 2Q17 Results: Which Segment Fared Best?
In 2Q17, Abbott Laboratories' (ABT) Medical Devices segment reported a strong performance once again, registering a YoY sales growth of 89.2%.
- Market Realist•23 hours ago
Why Pfizer’s Sutent Could Witness a Modest Decline in 2017
In 2016, Pfizer’s (PFE) Sutent reported revenues of ~$1.1 billion, which represented a ~2% decline on a YoY (year-over-year) basis.
- Market Realist•2 days ago
Why US Policy Uncertainty Could Trip up Equities
Since Donald Trump took office, there has been a surge in business confidence on the hope that his new administration will cut corporate taxes.
